{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:38:23Z","timestamp":1793216303448,"version":"4.5.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Erectile dysfunction (ED) is highly prevalent among men with type 2 diabetes mellitus (T2DM) and reflects systemic vascular and metabolic dysfunction. Shared mechanisms include endothelial dysfunction, oxidative stress, inflammation, autonomic neuropathy, and hypogonadism. Therefore, ED may function not only as a complication of T2DM but also as an early clinical marker of cardiometabolic disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This narrative review summarizes current evidence on the epidemiology, mechanisms, and cardiometabolic implications of ED in men with T2DM, and evaluates the impact of major cardiometabolic therapies on erectile function. A real-world cohort study was conducted using the TriNetX Global Collaborative Network, a large federated electronic health record database comprising healthcare organizations across multiple countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>ED is closely linked with hypertension, obesity, dyslipidaemia, heart failure, ischemic heart disease, and stroke in men with T2DM, reflecting shared microvascular and macrovascular diseases. Cohort and real-world studies indicate a strong bidirectional relationship: poor cardiometabolic control worsens erectile function, whereas improvements in glycaemia, weight, blood pressure, and lipids are associated with higher International Index of Erectile Function (IIEF) scores. Using data from the TriNetX Global Collaborative Network, large-scale real-world analyses further demonstrate that the coexistence of ED and T2DM substantially increases cardiovascular risk. In a propensity-score-matched cohort (&amp;gt;200,000 individuals per group), men with ED and T2DM had higher risks of ischemic heart disease (15.7% vs. 11.5%, OR: 1.44; 95% CI 1.41-1.46), stroke (OR 1.45; 95% CI 1.42-1.48), peripheral artery disease (OR 1.38; 95% CI 1.35-1.41), and heart failure (8.4% vs. 4.9%, OR 1.78; 95% CI 1.74-1.81). Conversely, among individuals with T2DM, the presence of ED was associated with increased ischemic heart disease, stroke, and peripheral artery disease. Mechanistic and clinical data suggest heterogeneous treatment effects: GLP-1 receptor agonists and SGLT2 inhibitors show promising vascular benefits with mixed erectile outcomes, whereas ARBs and finerenone appear favorable compared with older agents associated with sexual adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ED in T2DM should be regarded as a clinically relevant marker of systemic vascular disease. Routine assessment may enhance cardiovascular risk stratification and motivate earlier, comprehensive risk-factor intervention. Future prospective and randomized studies with erectile function as a predefined endpoint are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcdhc.2026.1781581","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:14:29Z","timestamp":1772799269000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Erectile dysfunction, type 2 diabetes, and cardiovascular disease: a narrative review and insights from a global real-world cohort analysis"],"prefix":"10.3389","volume":"7","author":[{"given":"Santiago","family":"Mart\u00ednez Mores","sequence":"first","affiliation":[{"name":"Department of Endocrinology & Nutrition, IR SANT PAU, Hospital de la Santa Creu i Sant Pau Institut de Recerca Sant Pau (IR SANT PAU)","place":["Barcelona, Spain"]},{"name":"Departamento de Medicina, Facultad de Medicina y Ciencias de la Salud, Universitat de Barcelona","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[{"name":"Grup de Recerca Epidemiol\u00f2gica en Diabetis des de l\u00b4Atenci\u00f3 Prim\u00e0ria (DAP_CAT) group, Unitat de Suport a la Recerca Barcelona, Fundaci\u00f3 Institut Universitari per a la recerca a l\u2019Atenci\u00f3 Prim\u00e0ria de Salut Jordi Gol i Gurina (IDIAPJGol)","place":["Barcelona, Spain"]},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas, Instituto de Salud Carlos III-Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas, Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didac","family":"Mauricio","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Nutrition, IR SANT PAU, Hospital de la Santa Creu i Sant Pau Institut de Recerca Sant Pau (IR SANT PAU)","place":["Barcelona, Spain"]},{"name":"Grup de Recerca Epidemiol\u00f2gica en Diabetis des de l\u00b4Atenci\u00f3 Prim\u00e0ria (DAP_CAT) group, Unitat de Suport a la Recerca Barcelona, Fundaci\u00f3 Institut Universitari per a la recerca a l\u2019Atenci\u00f3 Prim\u00e0ria de Salut Jordi Gol i Gurina (IDIAPJGol)","place":["Barcelona, Spain"]},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas, Instituto de Salud Carlos III-Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas, Instituto de Salud Carlos III","place":["Madrid, Spain"]},{"name":"Faculty of Medicine, University of Vic\/Central University of Catalonia (UVIC\/UCC)","place":["Vic, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Vlacho","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Nutrition, IR SANT PAU, Hospital de la Santa Creu i Sant Pau Institut de Recerca Sant Pau (IR SANT PAU)","place":["Barcelona, Spain"]},{"name":"Grup de Recerca Epidemiol\u00f2gica en Diabetis des de l\u00b4Atenci\u00f3 Prim\u00e0ria (DAP_CAT) group, Unitat de Suport a la Recerca Barcelona, Fundaci\u00f3 Institut Universitari per a la recerca a l\u2019Atenci\u00f3 Prim\u00e0ria de Salut Jordi Gol i Gurina (IDIAPJGol)","place":["Barcelona, Spain"]},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas, Instituto de Salud Carlos III-Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas, Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"B1","unstructured":"Atlas de la Diabetes de la FID\n          \n          \n          \n          2021"},{"key":"B2","volume-title":"IDF diabetes atlas","year":"2013"},{"key":"B3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.diabres.2016.04.016","article-title":"IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes","volume":"117","author":"da Rocha Fernandes","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S011","article-title":"Standards of medical care in diabetes\u20142010","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-003-2479-7","article-title":"The physiology of erectile dysfunction","volume":"28","author":"Russell","year":"2003","journal-title":"Herz"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/BF01294663","article-title":"Involvement of superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits","volume":"25","author":"Kim","year":"1997","journal-title":"Urol Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"104802","DOI":"10.1016\/j.amsu.2022.104802","article-title":"Novel insights on the role of VCAM-1 and ICAM-1: potential biomarkers for cardiovascular diseases","volume":"84","author":"Kaur","year":"2022","journal-title":"Ann Med Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/BF00191219","article-title":"Age-related increase in an advanced glycation end product in penile tissue","volume":"13","author":"Jiaan","year":"1995","journal-title":"World J Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2000.00599.x","article-title":"Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin","volume":"85","author":"Cartledge","year":"2000","journal-title":"BJU Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00770.2002","article-title":"Gene transfer of extracellular SOD to the penis reduces O2\u2013 and improves erectile function in aged rats","volume":"284","author":"Bivalacqua","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00512-8","article-title":"Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS","volume":"50","author":"Seftel","year":"1997","journal-title":"Urology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jama.1993.03510010089036","article-title":"NIH consensus development panel on impotence. Impotence","volume":"270","year":"1993","journal-title":"JAMA"},{"key":"B13","article-title":"EAU Guidelines on Sexual and Reproductive Health 2025","year":"2025"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70099","article-title":"Erectile dysfunction in diabetes mellitus: a comprehensive narrative review of pathophysiology, genetic association studies and therapeutic approaches","volume":"8","author":"Hostnik","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-5347%2817%2934871-1","article-title":"Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Ageing Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900622","article-title":"Epidemiology of erectile dysfunction: results of the \u201cCologne Male Survey","volume":"12","author":"Braun","year":"2000","journal-title":"Int J Impot Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347%2805%2965986-1","article-title":"Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study","volume":"166","author":"Martin-Morales","year":"2001","journal-title":"J Urol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.01168.x","article-title":"Erectile dysfunction in diabetes mellitus","volume":"6","author":"Malavige","year":"2009","journal-title":"J Sex Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.2.207","article-title":"Predictors and prevalence of erectile dysfunction in a racially diverse population","volume":"166","author":"Saigal","year":"2006","journal-title":"Arch Intern Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12601","article-title":"Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors","volume":"11","author":"Corona","year":"2014","journal-title":"J Sex Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2016.23","article-title":"Molecular mechanisms associated with diabetic endothelial-erectile dysfunction","volume":"13","author":"Castela","year":"2016","journal-title":"Nat Rev Urol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2007.03.007","article-title":"ED2: erectile dysfunction = endothelial dysfunction","volume":"36","author":"Guay","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1743-6109.2005.20104_1.x","article-title":"Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel","volume":"2","author":"Billups","year":"2005","journal-title":"J Sex Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1342658","article-title":"Inflammatory cytokine profiles in erectile dysfunction: a bidirectional Mendelian randomisation","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519893858","article-title":"Levels of soluble cell adhesion molecules in type 2 diabetes mellitus patients with macrovascular complications","volume":"48","author":"Hegazy","year":"2020","journal-title":"J Int Med Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.eururo.2013.08.048","article-title":"A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment\u2014A systematic review","volume":"65","author":"Isidori","year":"2014","journal-title":"Eur Urol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0804","article-title":"Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes","volume":"89","author":"Dhindsa","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490601","article-title":"Sex hormones, inflammation and the metabolic syndrome: a population-based study","volume":"149","author":"Laaksonen","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008832","article-title":"Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men","volume":"143","author":"Haffner","year":"1996","journal-title":"Am J Epidemiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302009000800002","article-title":"The role of testosterone in type 2 diabetes and metabolic syndrome in men","volume":"53","author":"Saad","year":"2009","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0943","article-title":"Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men","volume":"162","author":"Vikan","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.2.3766","article-title":"Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: the Telecom Study 1","volume":"82","author":"Simon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.5.405","article-title":"Testosterone concentrations in women and men with NIDDM","volume":"17","author":"Andersson","year":"1994","journal-title":"Diabetes Care"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2190","article-title":"Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men","volume":"90","author":"Pitteloud","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/01485010600692017","article-title":"total testosterone, sex hormone-binding globulin, leptin, insulin and insulin resistance in obese men","volume":"52","author":"Osuna","year":"2006","journal-title":"Arch Androl"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05349.x","article-title":"Glycosylated haemoglobin levels and the severity of erectile function in diabetic men","volume":"95","author":"Rhoden","year":"2005","journal-title":"BJU Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05728.x","article-title":"Diabetes mellitus is associated with subnormal serum levels of free testosterone in men","volume":"96","author":"Rhoden","year":"2005","journal-title":"BJU Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.01.054","article-title":"Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms","volume":"77","author":"Yagihashi","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051227","article-title":"Experimental diabetic neuropathy: an update","volume":"42","author":"Sima","year":"1999","journal-title":"Diabetologia"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/endo.136.12.7588327","article-title":"Reduction of penile nitric oxide synthase in diabetic BB\/WORdp (type I) and BBZ\/WORdp (type II) rats with erectile dysfunction","volume":"136","author":"Vernet","year":"1995","journal-title":"Endocrinology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1988.tb09164.x","article-title":"The value of testing for unmyelinated fibre sensory neuropathy in diabetic impotence","volume":"61","author":"Fowler","year":"1988","journal-title":"Br J Urol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.052712499","article-title":"Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection","volume":"99","author":"Hurt","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/BF00251005","article-title":"The prevalence of diabetic impotence","volume":"18","author":"McCulloch","year":"1980","journal-title":"Diabetologia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1464-5491.2005.01789.x","article-title":"Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus","volume":"23","author":"Cho","year":"2006","journal-title":"Diabetes Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2005.07.011","article-title":"Predictors for erectile dysfunction among diabetics","volume":"71","author":"Zheng","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1046\/j.0742-3071.2001.00557.x","article-title":"Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients","volume":"18","author":"Siu","year":"2001","journal-title":"Diabetes Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.2.135","article-title":"Prevalence of self-reported erectile dysfunction in people with long-term IDDM","volume":"19","author":"Klein","year":"1996","journal-title":"Diabetes Care"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.11.1973","article-title":"Erectile dysfunction in diabetic subjects in Italy","volume":"21","author":"Fedele","year":"1998","journal-title":"Diabetes Care"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.5551\/jat.9316","article-title":"Five-item version of the International Index of Erectile Function correlated with albuminuria and subclinical atherosclerosis in men with type 2 diabetes","volume":"18","author":"Fukui","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2016.40","article-title":"Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: the Dogo Study","volume":"29","author":"Furukawa","year":"2017","journal-title":"Int J Impot Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1053\/j.semvascsurg.2019.02.001","article-title":"The diabetic foot: pathophysiology, evaluation, and treatment","volume":"31","author":"Bandyk","year":"2018","journal-title":"Semin Vasc Surg"},{"key":"B52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s42000-022-00407-5","article-title":"Association of erectile dysfunction with diabetic foot and its outcomes in type 2 diabetic men","volume":"22","author":"Coppola","year":"2023","journal-title":"Hormones"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2011.01.009","article-title":"Erectile dysfunction is associated with severe retinopathy in diabetic men","volume":"77","author":"Henis","year":"2011","journal-title":"Urology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12099","article-title":"Relationship between diabetic retinopathy, diabetic macular oedema and erectile dysfunction in type 2 diabetics","volume":"41","author":"Chew","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/medicina59050969","article-title":"The associations between kidney function and sexual dysfunction among males and females with type 2 diabetes mellitus","volume":"59","author":"Katsimardou","year":"2023","journal-title":"Med (Kaunas)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.1038\/s41598-024-59844-4","article-title":"Male sexual dysfunction in patients with chronic kidney disease: a cross-sectional study","volume":"14","author":"Fu","year":"2024","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.21037\/tau-2024-751","article-title":"Prevalence and determinants of erectile dysfunction among male type 2 diabetes mellitus patients with chronic kidney disease: a cross-sectional study","volume":"14","author":"Muniandy","year":"2025","journal-title":"Transl Androl Urol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1368079","article-title":"Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis","volume":"15","author":"Dilixiati","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"108669","DOI":"10.1016\/j.jdiacomp.2023.108669","article-title":"Prevalence and predictors of erectile dysfunction among men in the Diabetes Prevention Program Outcomes Study","volume":"38","author":"Blair","year":"2024","journal-title":"J Diabetes Complications"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002382","article-title":"Update of the position paper on arterial hypertension and erectile dysfunction","volume":"38","author":"Viigimaa","year":"2020","journal-title":"J Hypertens"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2174\/092986707781058931","article-title":"Dyslipidemia as a risk factor for erectile dysfunction","volume":"14","author":"Vrentzos","year":"2007","journal-title":"Curr Med Chem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmy149","article-title":"Progression of carotid artery disease could stratify a risk of coronary artery disease patients with type 2 diabetes","volume":"51","author":"Bosevski","year":"2019","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.180026","article-title":"Obesity and erectile dysfunction: from bench to clinical implication","volume":"37","author":"Moon","year":"2019","journal-title":"World J Mens Health"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1135024","article-title":"Association of BMI with erectile dysfunction: A cross-sectional study of men from an andrology clinic","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01458.x","article-title":"Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD Trial","volume":"7","author":"Wing","year":"2010","journal-title":"J Sex Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.063374","article-title":"Twenty years of cardiovascular complications and risk factors in patients with type 2 diabetes: a nationwide Swedish cohort study","volume":"147","author":"Sattar","year":"2023","journal-title":"Circulation"},{"key":"B67","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12933-021-01344-0","article-title":"CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries","volume":"20","author":"Mosenzon","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.amjcard.2005.07.006","article-title":"The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease","volume":"96","author":"Montorsi","year":"2005","journal-title":"Am J Cardiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl142","article-title":"Association between erectile dysfunction and coronary artery disease: role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial","volume":"27","author":"Montorsi","year":"2006","journal-title":"Eur Heart J"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2007.01808.x","article-title":"Severity of coronary artery disease and symptoms of erectile dysfunction in males with a positive exercise treadmill test","volume":"14","author":"Akilli","year":"2007","journal-title":"Int J Urol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2019.04.004","article-title":"Erectile dysfunction predicts cardiovascular events as an independent risk factor: a systematic review and meta-analysis","volume":"16","author":"Zhao","year":"2019","journal-title":"J Sex Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12715","article-title":"Changes in erectile dysfunction over time in relation to Framingham cardiovascular risk in the Boston Area Community Health (BACH) Survey","volume":"12","author":"Fang","year":"2015","journal-title":"J Sex Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-011-9523-9","article-title":"Erectile dysfunction can improve the effectiveness of the current guidelines for screening for asymptomatic coronary artery disease in diabetes","volume":"40","author":"Gazzaruso","year":"2011","journal-title":"Endocrine"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0294","article-title":"Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes","volume":"36","author":"Turek","year":"2013","journal-title":"Diabetes Care"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.06.015","article-title":"The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease","volume":"87","author":"Nehra","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.10.069","article-title":"Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors","volume":"51","author":"Gazzaruso","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.04.067","article-title":"Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial","volume":"56","author":"Batty","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.13-2-136","article-title":"Erectile dysfunction in general medicine","volume":"13","author":"Grant","year":"2013","journal-title":"Clin Med (Lond)"},{"key":"B80","article-title":"Causal association between erectile dysfunction and the risk of myocardial infarction: A two-sample bidirectional Mendelian randomization study","volume":"31","author":"Zhang","year":"2025","journal-title":"Zhonghua Nan Ke Xue"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2009.06.003","article-title":"Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes","volume":"35","author":"Hermans","year":"2009","journal-title":"Diabetes Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.37349\/ec.2025.101283","article-title":"Vascular and neural mechanisms linking sexual dysfunction and peripheral artery disease in patients with diabetes","volume":"3","author":"Birg\u00fcn","year":"2025","journal-title":"Explor Cardiol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1439609","article-title":"Association of erectile dysfunction and peripheral arterial disease in NHANES 2001-2004: a cross-sectional study","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.05.005","article-title":"The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing","volume":"207","author":"Polonsky","year":"2009","journal-title":"Atherosclerosis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.21037\/tau-20-999","article-title":"Analysis of cardiovascular risks for erectile dysfunction in Chinese patients with type 2 diabetes mellitus lacking clinical symptoms of cardiovascular diseases","volume":"9","author":"Yuan","year":"2020","journal-title":"Transl Androl Urol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.05.052","article-title":"Erectile dysfunction in heart failure patients","volume":"48","author":"Schwarz","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-023-00632-y","article-title":"Heart failure and erectile dysfunction: a review of the current evidence and clinical implications","volume":"20","author":"Carella","year":"2023","journal-title":"Curr Heart Fail Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.02.051","article-title":"Erectile dysfunction predicts coronary heart disease in type 2 diabetes","volume":"51","author":"Ma","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2022.09.004","article-title":"Erectile dysfunction, phosphodiesterase-5 inhibitor use and risk of cardiovascular disease and mortality in people with diabetes: a systematic review and meta-analysis","volume":"16","author":"Seidu","year":"2022","journal-title":"Prim Care Diabetes"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2008.36","article-title":"Does cardiovascular risk reduction alleviate erectile dysfunction in men with type II diabetes mellitus","volume":"20","author":"Khatana","year":"2008","journal-title":"Int J Impot Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1349069","article-title":"Emerging role of antidiabetic drugs in cardiorenal protection","volume":"15","author":"Fu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073651","article-title":"An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors","volume":"23","author":"Salvatore","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S503216","article-title":"Effects of anti-diabetic drugs on erectile dysfunction: A systematic review and meta-analysis","volume":"18","author":"Yang","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B94","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1016\/j.eprac.2025.05.549","article-title":"Impact of SGLT2 inhibitors on erectile dysfunction in male patients with type 2 diabetes mellitus: A retrospective cohort analysis","volume":"31","author":"Lam","year":"2025","journal-title":"Endocrine Pract"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/biom15091284","article-title":"The impact of glucagon-like peptide-1 receptor agonists on erectile function: friend or foe","volume":"15","author":"Kounatidis","year":"2025","journal-title":"Biomolecules"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00115-7","article-title":"Erectile function in men with type 2 diabetes treated with dulaglutide: An exploratory analysis of the REWIND placebo-controlled randomized trial","volume":"9","author":"Bajaj","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12099","article-title":"Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism","volume":"3","author":"Giagulli","year":"2015","journal-title":"Andrology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1448394","article-title":"Glucagon-like peptide-1 receptor agonists and the risk of erectile dysfunction: A drug target Mendelian randomization study","volume":"15","author":"An","year":"2024","journal-title":"Front Endocrinol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-025-01061-2","article-title":"Male sexual dysfunction associated with GLP-1 receptor agonists: A cross-sectional analysis of FAERS data","volume":"37","author":"Pourabhari Langroudi","year":"2025","journal-title":"Int J Impot. Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.3390\/jcm12196285","article-title":"Nonsteroidal mineralocorticoid receptor antagonist (finerenone) in cardiorenal disease","volume":"12","author":"Shah","year":"2023","journal-title":"J Clin Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2005.05285.x","article-title":"The effect of antihypertensive drugs on erectile function: A proposed management algorithm","volume":"8","author":"Doumas","year":"2006","journal-title":"J Clin Hypertension"},{"key":"B103","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/amsr.amsr_39_23","article-title":"Efficacy of angiotensin receptor blockers for erectile dysfunction in hypertensive men: A systematic review","volume":"3","author":"Dash","year":"2024","journal-title":"Ann Med Sci Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1177\/1557988319892735","article-title":"Angiotensin receptor blockers for erectile dysfunction in hypertensive men: A brief meta-analysis of randomized control trials","volume":"13","author":"Ismail","year":"2019","journal-title":"Am J Mens Health"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1191\/1358863x03vm509ra","article-title":"Effect of sildenafil on arterial stiffness and wave reflection","volume":"8","author":"Vlachopoulos","year":"2003","journal-title":"Vasc Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0700","article-title":"Therapy of endocrine disease: effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis","volume":"172","author":"Santi","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21037\/tau.2016.10.01","article-title":"Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies","volume":"6","author":"Sanchez","year":"2017","journal-title":"Transl Androl Urol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10557-021-07275-y","article-title":"Cardiac effects of phosphodiesterase-5 inhibitors: efficacy and safety","volume":"37","author":"Roy","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"B109","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/jsxmed\/qdac005","article-title":"Effect of phosphodiesterase type 5 inhibitors on major adverse cardiovascular events and overall mortality in a large nationwide cohort of men with erectile dysfunction and cardiovascular risk factors: a retrospective, observational study based on healthcare claims and national death index data","volume":"20","author":"Kloner","year":"2023","journal-title":"J Sex Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvae029","article-title":"Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis","volume":"10","author":"Soulaidopoulos","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-012-0249-5","article-title":"Chronic treatment with long-acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in type 2 diabetic hearts","volume":"107","author":"Koka","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00865.2013","article-title":"Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO\/SIRT1\/PGC-1\u03b1 signaling","volume":"306","author":"Koka","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1781581\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:14:32Z","timestamp":1772799272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1781581\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":112,"alternative-id":["10.3389\/fcdhc.2026.1781581"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2026.1781581","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"article-number":"1781581"}}